Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/00002826-200303000-00001 | DOI Listing |
BMJ Case Rep
December 2024
Ophthalmology, LLH Hospital, Abu Dhabi, Abu Dhabi, UAE.
Fatigue is a common symptom encountered in clinical practice, often posing a diagnostic challenge due to its myriad underlying causes. A comprehensive clinical history can serve as a valuable guide in such diagnostic dilemmas. A man in his 30s presented with a history of intermittent fatigue.
View Article and Find Full Text PDFPoult Sci
January 2025
Department of Animal Science, College of Agriculture and Natural Resources, Razi University, Kermanshah, Iran.
The present study evaluated the effects of 1α-hydroxycholecalciferol (1αOHD) supplementation on performance, egg quality, gut morphology, serum metabolites, and bone characteristics of Lohman LSL-Lite laying hens. A total of 180 birds (110 weeks of age) were allocated according to a completely randomized design with five treatments. Each treatment had six replicates containing six hens each.
View Article and Find Full Text PDFSurgery
February 2025
Department of General and Endocrine Surgery, Pitié Salpêtrière Hospital, APHP, Sorbonne University, Paris, France; Groupe de Recherche Clinique No. 16 Thyroid Tumors, Sorbonne University, Paris, France.
J Nutr Sci Vitaminol (Tokyo)
October 2024
Department of Rehabilitation, Ichinomiya Medical Treatment & Habilitation Center.
Patients with severe motor and intellectual disabilities (SMID) often experience insufficient physical activity, leading to osteoporosis. The active form of vitamin D is commonly prescribed for the prevention or treatment of osteoporosis. We observed four cases of kidney injury believed to be associated with the administration of 1α-OH vitamin D (alfacalcidol) preparations.
View Article and Find Full Text PDFMetab Brain Dis
December 2024
Department of Neurology, Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
This study was to investigate the mechanism of Changma Xifeng tablet, a traditional Chinese medicine in the treatment of Tourette syndrome. Network pharmacology was utilized to pinpoint blood-entering constituents of Changma Xifeng and explore their potential targets. Additionally, differential microRNA expression analysis was conducted to predict Tourette syndrome-associated targets, complemented by molecular docking and dynamics simulations to support the interactions of the active compounds with these targets.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!